Why wasn't the APPROVe trial stopped earlier?
The APPROVe trial began enrollment in 2000 and was being monitored by an independent data safety monitoring board (DSMB). It was not stopped earlier because the results for the first 18 months of the trial did not show that Vioxx carried any increased risk of cardiovascular events.
The information on this page is meant to provide a general overview of the law. The laws in your state and/or city may deviate significantly from those described here. If you have specific questions related to your situation you should speak with a local attorney.
Additional Vioxx Articles
- What is Vioxx?
- What is the COX enzyme?
- Why has Vioxx been withdrawn from the market?
- Were there any warning flags that led to Merck's recall of Vioxx?
- What evidence supports the withdrawal?
- Did the Food and Drug Administration (FDA) require this action?
- What action did the FDA take?
- What did the FDA know about the risk of heart attack and stroke when it approved Vioxx?
- What are NSAIDs?
- Does the withdrawal of Vioxx from the market suggest that other drugs in the same class are dangerous?
- Was there a request for a Vioxx recall by the FDA?
- Can my pharmacist continue to fill my prescription for Vioxx?
- What other drugs are similar to Vioxx?
- I had a prescription for Vioxx, and now that Vioxx is off the market, what questions should I ask my doctor in choosing a different COX-2 inhibitor?
- How can I report a serious Vioxx side effect to the FDA?
- Where can I get more information on Vioxx?